Diagnosing Non-Celiac Gluten Sensitivity (NCGS)
Non-celiac gluten sensitivity is diagnosed through a systematic exclusion process followed by a double-blind placebo-controlled gluten challenge, after first ruling out celiac disease and wheat allergy. 1
Step 1: Exclude Celiac Disease
Before considering NCGS, you must definitively rule out celiac disease:
- Serology testing: Measure IgA tissue transglutaminase (TG2-IgA) antibodies, IgA endomysial antibodies (EMA), and check total IgA levels 2, 3
- Duodenal biopsy: If serology is positive or clinical suspicion is high, perform upper endoscopy with at least 4 biopsies from the distal duodenum and duodenal bulb 3
- Critical caveat: The patient must be consuming gluten at the time of testing—testing on a gluten-free diet invalidates results 2
- HLA typing: Consider HLA-DQ2/DQ8 testing only if results are equivocal; negative HLA has high negative predictive value for excluding celiac disease 2
The threshold for celiac disease diagnosis requires villous atrophy on biopsy, though ≥25 intraepithelial lymphocytes per 100 enterocytes combined with positive serology may represent "probable CD" 3.
Step 2: Exclude Wheat Allergy
Rule out IgE-mediated wheat allergy through:
- Specific IgE antibodies to wheat
- Skin prick testing
- Clinical history of rapid-onset reactions (respiratory, gastrointestinal, or anaphylactic symptoms) 4, 5
Step 3: Confirm NCGS Diagnosis
Once celiac disease and wheat allergy are excluded, NCGS diagnosis requires demonstrating symptom improvement on a gluten-free diet followed by symptom recurrence with gluten reintroduction 1, 6.
The Salerno Experts' Criteria (Gold Standard for Research):
Double-blind placebo-controlled gluten challenge 1:
- Patient follows strict gluten-free diet initially
- Identify 1-3 main symptoms and rate them on a numerical scale (1-10)
- Administer 8g gluten daily for one week in cooked, homogeneously distributed vehicle
- One-week washout period on strict gluten-free diet
- Crossover to placebo challenge for one week
- Positive diagnosis: ≥30% variation in symptom scores between gluten and placebo challenges
Practical Clinical Approach:
For real-world practice, a single-blind placebo-controlled rechallenge is more feasible 6:
- Document baseline symptoms while patient is on regular gluten-containing diet
- Implement strict gluten-free diet for 6-8 weeks
- Assess symptom improvement using standardized scales (modified Gastrointestinal Symptom Rating Scale) 1
- Perform blinded gluten rechallenge
- Document symptom recurrence
Important Clinical Pitfalls
The nocebo effect is substantial in NCGS studies 6. Many patients who believe they have gluten sensitivity do not demonstrate symptoms during properly blinded challenges. This underscores why objective rechallenge testing is essential rather than relying solely on patient self-report.
NCGS has no validated biomarkers 6, 7, 8. Some patients may show:
- IgG antigliadin antibodies (10% of cases) 9
- HLA-DQ2/DQ8 positivity (75% of cases, but this doesn't confirm diagnosis) 9
- These findings are non-specific and cannot be used diagnostically
Consider alternative diagnoses, particularly:
- Irritable bowel syndrome (IBS)
- FODMAP sensitivity (fructans in wheat may be the actual trigger, not gluten) 6, 8
- Small intestinal bacterial overgrowth
- Other functional gastrointestinal disorders
The overlap between NCGS and IBS is substantial, and many patients may actually be responding to wheat FODMAPs rather than gluten itself 8.
Multidisciplinary Team Approach
Involve a nutritionist/dietitian who can:
- Guide proper gluten elimination
- Ensure nutritional adequacy during gluten-free diet
- Help identify hidden gluten sources
- Consider low-FODMAP diet as alternative or adjunct 6, 8
Warning about long-term gluten-free diets: These can lead to nutritional deficiencies (fiber, B vitamins, iron) and should not be undertaken without proper diagnosis 6, 8.
Clinical Presentation to Look For
Gastrointestinal symptoms: Bloating, abdominal pain, diarrhea, flatulence, reflux 1, 10
Extraintestinal symptoms: Fatigue, headache, "foggy mind," joint/muscle pain, skin manifestations, neuropsychiatric symptoms 1, 8
Temporal relationship: Symptoms typically occur within hours to days of gluten ingestion and improve within days to weeks of gluten withdrawal 1, 4
The diagnosis of NCGS remains challenging and somewhat controversial within gastroenterology 6. The absence of objective biomarkers means diagnosis relies heavily on careful clinical evaluation and properly conducted dietary challenges. Without performing a blinded rechallenge, you cannot distinguish true NCGS from placebo effects or other conditions.